Kestra Medical Technologies (KMTS) Accumulated Expenses (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Accumulated Expenses data on file, last reported at $2.8 million in Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $2.8 million, down 78.82% year-over-year; the trailing twelve-month figure through Jan 2026 was $2.8 million (down 78.82% YoY), and the FY2025 annual result was $2.3 million, up 885.04% from the prior year.
• Accumulated Expenses declined to $2.8 million in Q1 2026 per KMTS's latest filing, from $15.5 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $15.5 million in Q4 2025 and troughed at $234000.0 in Q2 2024.
• A 3-year average of $6.0 million and a median of $2.5 million in 2025 frame the typical range for Accumulated Expenses.
• The sharpest annual moves came in 2025 and 2026: Accumulated Expenses soared 885.04% in 2025, then tumbled 78.82% in 2026.
• A 3-year view of Accumulated Expenses shows it stood at $234000.0 in 2024, then surged by 6521.37% to $15.5 million in 2025, then slumped by 82.18% to $2.8 million in 2026.
• Business Quant data shows KMTS's Accumulated Expenses at $2.8 million in Q1 2026, $15.5 million in Q4 2025, and $2.2 million in Q3 2025.